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Background: The aim of this study was to assess the relationship between health-related  quality 
of life (HRQoL) and the presence or absence of hypertension and diabetes-related chronic 
complications in type 2 diabetes, and also the association between HRQoL and the number of 
chronic complications.
Methods: One hundred patients with type 2 diabetes were interviewed. HRQoL was evaluated 
using the age-adjusted Short-Form 36 dimensions (physical functioning, role-physical, bodily 
pain, general health, vitality, social functioning, role-emotional, and mental health).
Results: The mean age of the study population was 62.7±8.7 years; 54.0% were male, and 
51.0% were receiving only oral hypoglycemic agents. Chronic complications were related to 
worse HRQoL in different dimensions: peripheral neuropathy and cardiovascular disease (all, 
except bodily pain), retinopathy (physical functioning, general health, vitality, and mental 
health), peripheral arterial disease (physical functioning, role-physical, and general health), and 
nephropathy (general health and vitality). Hypertension was related to worse general health and 
vitality. An increased number of chronic complications was associated with worse HRQoL in 
all dimensions of Short-Form 36 except for the bodily pain dimension.
Conclusion: The presence and increased number of diabetes-related chronic complications, and 
the presence of hypertension were related to worse age-adjusted HRQoL. Peripheral neuropathy 
and cardiovascular disease were more strongly related to age-adjusted HRQoL.
Keywords: retinopathy, nephropathy, peripheral neuropathy, cardiovascular disease, peripheral 
arterial disease
Introduction
Health-related quality of life (HRQoL) is a subjective assessment of the patient1 that 
is related to the perception of their health,1–4 well-being, and functioning,1 and also to 
their worries about the future.4 Although the term HRQoL is not yet precisely defined,5 
it is a useful measure to assess the overall impact of a particular nosological entity 
in patient,2 and it complements the clinical information.3,6 There are several generic 
tools that can be used to assess HRQoL; they can be used not only in the healthy 
population but also in specific populations4 because they allow to assess a wide set of 
important dimensions that can be used in different diseases.4,6–8 Wilson and Cleary9 
propose a conceptual model to explain the relationships between clinical variables 
and measures of HRQoL in order to establish the connection between diagnosis and 
therapy and, thus, to increase patients’ HRQoL. This classification is divided into 
five levels –  biological and physiological factors, symptoms, functioning, general 
health perceptions, and overall quality of life – and proposes causal relationships 
between all of them.
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With regard to the relationship between HRQoL, the pres-
ence of hypertension (HTN), and diabetes-related chronic 
complications, the literature is not consistent in pointing out 
that their presence decreases HRQoL and, hence, the impor-
tance of evaluating the relationship between these variables 
and HRQoL. Moreover, as far as we know, the only two 
researches carried out in Portugal5,10 that have assessed the 
relationship between the most frequent chronic  complications 
of diabetes and HRQoL did not make the adjustment of the 
HRQoL scores for any demographic and/or clinical variables 
that can mediate some of these relationships. On the other 
hand, the study sample of these two studies was quite hetero-
geneous – they  evaluated  simultaneously type 1 and type 2 
diabetic patients – and did not assess chronic  complications 
according to diabetes type. Lastly, the  investigations that 
evaluated the  relationship between the number of diabetes-
related chronic  complications and HRQoL did not make 
stratified analyses according to sex that can bring important 
supplemental information to the one achieved for the whole 
sample.
Concerning microvascular complications of diabetes, 
while some studies10–12 have found that the presence of dia-
betic retinopathy was related to worse HRQoL, Sakamaki 
et al13 found no relationship between the two variables. 
Results of research on the relationship between diabetic 
nephropathy and HRQoL have found, on one hand, that its 
presence was related to lower HRQoL10,11 and, on the other 
hand, no relationship between both variables.13 Concerning 
the relationship between diabetic neuropathy and HRQoL, 
while Sakamaki et al13 found no relationship between the two 
variables, some studies10,14–17 have found that its presence was 
related to worse HRQoL.
As far as diabetes-related macrovascular complications 
are concerned, although there is evidence that the presence of 
cardiovascular disease (CVD) in persons with diabetes was 
related to lower HRQoL,5,10,12,14–16,18–22 Wasem et al17 found no 
relationship between the two variables. Regarding the rela-
tionship between the presence of peripheral arterial disease 
(PAD) and HRQoL, Silva et al,5 Neves et al,10 Javanbakht 
et al,11 and Quah et al16 have shown that patients with this 
chronic complication had worse HRQoL, whereas Sakamaki 
et al13 and Wasem et al17 found no relationship between the 
two variables, and Venkataraman et al22 reported that its 
presence was related to better HRQoL.
Regarding the relationship between HTN and diabetes, 
while some studies5,10,23,24 have found that the presence 
of HTN was related to lower HRQoL, Wexler et al20 and 
Hill-Briggs et al25 reported no relationship between the two 
variables.
Finally, some researchers, looking at the  relationship 
between the number of diabetes-related chronic com-
plications and HRQoL, have found that an increased 
 number of  complications was related to worse HRQoL.16,26 
However, Caldwell et al27 did not find a relationship between 
the two variables.
The aim of this cross-sectional study was to assess the 
 relationship between HRQoL, the presence or absence of 
HTN, and diabetes-related micro- and macrovascular compli-
cations in type 2 diabetes, as well as the association between 
HRQoL and the number of chronic complications, for the 
whole sample and by sex. We focused on the assessment 
of HTN and long-term complications on HRQoL in type 2 
diabetic patients for three reasons: first, because HTN is a 
highly prevalent comorbidity in these individuals; second, 
because it is highly associated with diabetes-related chronic 
complications; and third, because it can have a negative asso-
ciation with HRQoL.
Subjects and methods
Study design and participants
A consecutive sample of 100 type 2 diabetic patients from 
the Outpatient Department of Endocrinology, Diabetes and 
Metabolism, Centro Hospitalar São João, Porto, Portugal, 
was recruited. Patients were included in the study if they 
had a diagnosis of type 2 diabetes, were at least 18 years old, 
and were not currently pregnant. The protocol for the study 
was approved by the Ethics Committee for Health of Centro 
Hospitalar São João, and informed consent was obtained from 
all participants before participating in the study.
Demographic and clinical data were collected based 
on medical records. General HRQoL was assessed by the 
Portuguese version of the Medical Outcomes Study 36-Item 
Short-Form Health Survey (SF-36),28,29 and it was adminis-
tered by one of the researchers.
clinical outcomes
We evaluated the presence of some clinical variables that are 
reported in the literature to be related to HRQoL among type 2 
diabetes;5,10–12,14–24,26 these factors included microvascular 
complications, macrovascular complications, and HTN.
Type 2 diabetic patients were classified as on “oral hypo-
glycemic agents” or “insulin therapy” (the latter including 
patients only on insulin therapy or on oral hypoglycemic agents 
plus insulin therapy). Duration of diabetes was  categorized 
as “,10 years”, “10–19 years”, or “20 years or more”.
Microvascular complications considered were diabetic 
retinopathy, diabetic nephropathy, and diabetic peripheral 
 neuropathy; macrovascular complications were CVD and PAD. 
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Table 2 health-related quality of life in patients with type 2 diabetes 
and its association with age
SF-36 dimensions Percent 
Mean (SD)
Association with age 
r (P-value)
Physical functioning 30.0 (32.6) -0.170 (0.092)
role-physical 31.3 (46.0) -0.127 (0.208)
Bodily pain 38.1 (32.5) 0.093 (0.358)
general health 44.0 (17.9) 0.080 (0.428)
Vitality 42.2 (26.1) -0.078 (0.440)
Social functioning 51.4 (26.8) -0.006 (0.952)
role-emotional 52.7 (49.3) -0.061 (0.544)
Mental health 47.9 (24.5) 0.012 (0.909)
Note: r, Pearson’s correlation coefficient.
Abbreviations: SF-36, Medical Outcomes Study 36-item Short-Form health 
Survey; SD, standard deviation.
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We considered that the patients had retinopathy if they had at 
least microaneurysms, nephropathy if they had at least  albumin 
excretion rate higher than 30 mg/g creatinine,  peripheral 
 neuropathy if they had two or more insensate sites across 
two feet for the 10 g monofilament or one or more insensate sites 
for the 128 Hz tuning fork. CVD was defined by the presence of 
at least one of the following conditions: angina pectoris or acute 
myocardial infarction or transient ischemic attack or stroke; and 
PAD was defined as an ankle-brachial index of #0.9 or a prior 
history of lower extremity revascularization.
HTN was defined by one of the following: systolic blood 
pressure $140 mmHg or diastolic blood pressure $90 mmHg 
or current use of antihypertensive agents or documented 
diagnosis of HTN.
hrQol measurement tool
The SF-36 Healthy Survey comprises 36 items covering 
 functional health status and general health, currently and over 
the past 4 weeks, and measures eight dimensions: physical 
functioning, role-physical, bodily pain, general health,  vitality, 
social functioning, role-emotional, and mental health. Raw 
dimension scores were transformed to scales ranging from 
0 to 100, in which higher scores indicate higher HRQoL.
Data analysis
Statistical Package for the Social Sciences version 20.0 for 
Windows software (IBM Corporation, Armonk, NY, USA) 
was used for the analysis. Descriptive statistical analysis 
included calculation of means and standard deviations for 
cardinal variables, and frequencies for ordinal and nominal 
variables. Independent samples t-tests were used to compare 
means of independent samples. The degree of association 
between pairs of variables was measured by Pearson’s (r) or 
Spearman’s (r
s
) correlation coefficients. Relationships were 
considered to be statistically significant at P,0.05.
As there were age-discrepancies within the sample 
(minimum age of 44 years old, and maximum age of 80 years 
old), we adjusted SF-36 results to the age of the participants; 
therefore, all other variables were related to the residuals of 
simple linear regression models having each dimension as a 
dependent variable and age as the independent variable.
Results
Demographic and diabetes-related data are presented in 
Table 1. We interviewed 100 patients with type 2 diabetes 
aged 44–80 years. Most patients were male, were  receiving 
only oral hypoglycemic agents, and had the disease 
for ,10 years. Only 21.0% of the patients did not have 
chronic complications related to diabetes. Among the chronic 
complications considered, the most prevalent was diabetic 
retinopathy, followed by CVD.
The average values obtained by patients in the eight dimen-
sions of the SF-36, as well as the association between these 
scores and age are shown in Table 2. There was no association 
between age and any of the eight dimensions of the SF-36.
The age-adjusted scores of HRQoL by the presence or 
absence of each of the microvascular complications of dia-
betes are shown in Table 3, macrovascular complications of 
diabetes in Table 4, and HTN in Table 5. There was an overall 
tendency for the presence of each of the chronic complications 
and HTN to be related to worse HRQoL in all dimensions of 
SF-36, regardless of age; the only exception was the dimension 
role-physical in diabetic nephropathy.
The complications related to larger number of dimensions 
were peripheral neuropathy and CVD (all dimensions except 
Table 1 Demographic and clinical characteristics of type 2 diabetic 
patients
Sex, n (%)
 Male 54 (54.0)
 Female 46 (46.0)
age (years), mean (SD) 62.7 (8.7)
Treatment groups of type 2 diabetes, n (%)
 Without insulin therapy 51 (51.0)
 With insulin therapy 49 (49.0)
Duration of diabetes (years), n (%)
  ,10 42 (42.0)
 10–19 32 (32.0)
  $20 26 (26.0)
Microvascular complications, n (%)
 retinopathy 51 (51.0)
 nephropathy 27 (27.0)
 Peripheral neuropathy 39 (39.0)
Macrovascular complications, n (%)
 cardiovascular disease 47 (47.0)
 Peripheral arterial disease 32 (32.0)
hypertension, n (%) 52 (52.0)
Abbreviation: SD, standard deviation.
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bodily pain). In type 2 diabetic patients with  retinopathy, PAD, 
and nephropathy, the HRQoL only differed on four, three, 
and two dimensions, respectively – retinopathy (physical 
functioning, general health, vitality, and mental health), PAD 
(physical functioning, role-physical, and general health), and 
nephropathy (general health and vitality). HTN was related to 
worse HRQoL in terms of general health and vitality. The most 
related dimensions to worse HRQoL were general health and 
vitality; the general health dimension was lower in patients 
with any of the long-term complications and HTN, whereas the 
vitality dimension was lower in HTN and all diabetes-related 
complications with the exception of PAD. On the other hand, 
the bodily pain was the dimension least related to HRQoL 
because it was not related to any of these variables.
The association between HRQoL and the number of 
chronic complications for the whole sample and by sex 
are shown in Table 6. An increased number of long-term 
complications tended to be associated with worse HRQoL 
in all dimensions of SF-36, regardless of age; the only 
exceptions were the bodily pain dimension in males and the 
role-emotional dimension in females. This association reached 
statistical significance in all dimensions with the exception 
of bodily pain in the total sample, all except bodily pain and 
social functioning in men, and only in general health, vitality, 
and mental health dimensions in women. In men, the most 
associated dimension of HRQoL with the number of chronic 
complications was physical functioning, followed by general 
health, and then by role-physical. In women, the most asso-
ciated dimensions with the number of complications were 
general health, followed by vitality. The dimensions physi-
cal functioning, role-physical, and role-emotional were only 
associated with the number of complications in males.
Discussion
The presence of diabetes-related chronic complications and 
HTN, as well as the number of complications were related 
to worse HRQoL regardless of age, with the different 
 conditions being related to different dimensions of HRQoL. 
The  adjustment of SF-36 scores for age may obscure rela-
tionships between diabetes-related complications, HTN, and 
Table 3 health-related quality of life in patients with type 2 diabetes and microvascular complications
SF-36 dimensions 
(adjusted for age)
Microvascular complications
Retinopathy Nephropathy Peripheral neuropathy
No 
Mean (SD)
Yes 
Mean (SD)
P-value No 
Mean (SD)
Yes 
Mean (SD)
P-value No 
Mean (SD)
Yes 
Mean (SD)
P-value
Physical functioning 10.9 (33.8) -10.5 (26.9) ,0.001 3.2 (33.8) -8.7 (25.8) 0.064 8.3 (34.0) -13.0 (24.2) ,0.001
role-physical 7.8 (48.3) -7.5 (42.0) 0.094 -2.3 (44.3) 6.2 (49.3) 0.409 10.0 (48.6) -15.6 (35.7) 0.003
Bodily pain 0.1 (30.5) -0.1 (34.3) 0.968 1.4 (32.4) -3.7 (32.6) 0.495 4.7 (32.8) -7.4 (30.6) 0.068
general health 7.4 (14.3) -7.1 (18.2) ,0.001 2.4 (17.9) -6.6 (16.4) 0.024 3.1 (17.4) -4.9 (17.8) 0.028
Vitality 9.1 (24.5) -8.7 (24.5) ,0.001 3.5 (25.2) -9.4 (26.3) 0.028 6.4 (24.5) -10.1 (25.4) 0.002
Social functioning 5.3 (26.4) -5.1 (26.4) 0.053 1.4 (26.7) -3.7 (27.1) 0.403 5.8 (25.0) -9.1 (27.1) 0.006
role-emotional 9.4 (47.4) -9.0 (49.7) 0.061 1.3 (48.9) -3.5 (50.8) 0.664 9.4 (48.6) -14.7 (47.1) 0.016
Mental health 7.7 (22.0) -7.4 (24.8) 0.002 0.7 (22.2) -1.8 (30.3) 0.698 5.6 (23.2) -8.8 (24.2) 0.004
Abbreviations: SF-36, Medical Outcomes Study 36-item Short-Form health Survey; SD, standard deviation.
Table 4 health-related quality of life in patients with type 2 diabetes and macrovascular complications
SF-36 dimensions 
(adjusted for age)
Macrovascular complications
Cardiovascular disease Peripheral arterial disease
No 
Mean (SD)
Yes 
Mean (SD)
P-value No 
Mean (SD)
Yes 
Mean (SD)
P-value
Physical functioning 8.9 (35.1) -10.0 (25.4) 0.003  5.5 (33.7) -11.7 (25.3) 0.006
role-physical 11.5 (48.4) -13.0 (38.7) 0.006 8.3 (48.1) -17.7 (34.1) 0.003
Bodily pain 3.6 (36.4) -4.0 (26.9) 0.235 1.6 (35.1) -3.5 (25.7) 0.412
general health 5.7 (16.8) -6.5 (17.0) ,0.001 2.5 (17.8) -5.3 (17.1) 0.040
Vitality 5.2 (26.5) -5.8 (24.4) 0.034 1.7 (25.8) -3.6 (26.5) 0.343
Social functioning 6.2 (24.7) -6.9 (27.6) 0.014 2.7 (26.3) -5.7 (27.3) 0.147
role-emotional 9.3 (47.7) -10.4 (49.2) 0.045 1.7 (49.2) -3.6 (49.7) 0.622
Mental health 5.8 (25.1) -6.5 (22.4) 0.012 3.0 (25.6) -6.3 (21.1) 0.078
Abbreviations: SF-36, Medical Outcomes Study 36-item Short-Form health Survey; SD, standard deviation.
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HRQoL dimensions that strongly depend on a concomitant 
relationship with age. Thereby, absolute scores on the SF-36 
and their relationship with long-term complications and HTN 
may have clinical usefulness, but to analyze their association 
with HRQoL, which was our intention, it is recommended 
that values are adjusted for age if there are significant age-
discrepancies within the sample.
Regarding the relationship between the presence of retin-
opathy and HRQoL, we found that having retinopathy was 
related to lower HRQoL in terms of physical  functioning, 
 general health, vitality, and mental health. Our results 
 partially overlap with the findings of Neves et al10 for three 
reasons: first, these Portuguese researchers have found that 
the  diabetic patients with retinopathy had worse HRQoL than 
those without retinopathy in all SF-36 dimensions; second, 
because in that study the authors included in their analysis 
a quite heterogeneous sample (ie, type 1 and type 2 diabetic 
patients), whereas we included a less heterogeneous one; 
and third, because they did not make the adjustment of the 
HRQoL scores for age. Conversely, a cross-sectional study13 
and a longitudinal study30 have found no relationship between 
the two variables. Contrary to what we expected, which was 
a reduced HRQoL in both physical and mental component 
scores of the SF-36, we found that diabetic retinopathy appears 
to have a greater relationship with the physical component 
than the mental one.
Our results showed that the presence of nephropathy was 
related to worse HRQoL in terms of general health and  vitality. 
These results are partially in agreement with the findings of 
Neves et al,10 because these authors reported that its presence 
was related to lower HRQoL in all dimensions of SF-36. 
However, as mentioned earlier, the study of Neves et al10 has 
methodological limitations that might have compromised the 
results. In contrast, two studies13,30 reported no relationship 
between the presence of nephropathy and HRQoL. Surpris-
ingly, we did not find differences between the two groups in 
the other dimensions of the SF-36, particularly in terms of 
mental component.
We found that the presence of peripheral neuropathy was 
related to worse HRQoL in all dimensions of SF-36 with the 
exception of the bodily pain dimension. These results are 
different from those obtained in another study,13 which did 
not find a relationship between peripheral neuropathy and 
HRQoL. Our results are consistent with the findings of Neves 
et al,10 given that in that study it was found that the presence 
of neuropathy was related to lower HRQoL in all dimensions 
of SF-36, and partially overlapping with the results of other 
investigations.15,16 In the first study it was reported that having 
neuropathy was related to worse HRQoL in terms of  physical 
functioning and bodily pain dimensions of SF-36, while in 
the latter one it was found that the presence of peripheral 
neuropathy was related to lower HRQoL in terms of physical 
and mental components of the aforementioned tool.
Concerning the relationship between the presence of CVD 
and HRQoL, Wasem et al17 reported no relationship between 
the two variables, whereas we found worse HRQoL in patients 
with CVD in all dimensions of SF-36 with the exception of 
bodily pain dimension when comparing with those that did 
not have the disease. These findings are partially in agreement 
with the results of four cross-sectional studies5,10,15,22 because 
in those studies, the presence of CVD was related to lower 
HRQoL in terms of physical functioning, general health,5,10,15,22 
role-physical,5,10,22 bodily pain, vitality,5,10,15 social functioning,15 
and physical component.15,22 On the other hand, our findings 
Table 5 health-related quality of life in patients with type 2 dia-
betes and hypertension
SF-36 dimensions  
(adjusted for age)
Hypertension
No 
Mean (SD)
Yes 
Mean (SD)
P-value
Physical functioning 5.4 (34.0) -5.0 (29.8) 0.111
role-physical 0.5 (46.1) -0.4 (45.6) 0.920
Bodily pain 4.2 (33.6) -3.9 (31.0) 0.209
general health 6.3 (17.9) -5.8 (15.9) ,0.001
Vitality 8.3 (28.5) -7.7 (20.9) 0.002
Social functioning 3.5 (28.6) -3.3 (24.8) 0.205
role-emotional 3.0 (49.8) -2.8 (49.0) 0.558
Mental health 4.0 (27.2) -3.7 (21.4) 0.125
Abbreviations: SF-36, Medical Outcomes Study 36-item Short-Form health 
Survey; SD, standard deviation.
Table 6 health-related quality of life and association with num-
ber of diabetes-related chronic complications
SF-36  
dimensions 
(adjusted for  
age)
Association with number of chronic 
complications
Total 
rs (P-value)
Male 
rs (P-value)
Female 
rs (P-value)
Physical  
functioning
-0.428 (,0.001) -0.542 (,0.001) -0.190 (0.206)
role-physical -0.277 (0.005) -0.427 (0.001) -0.054 (0.722)
Bodily pain -0.124 (0.221) 0.043 (0.759) -0.262 (0.079)
general health -0.470 (,0.001) -0.465 (,0.001) -0.431 (0.003)
Vitality -0.421 (,0.001) -0.353 (0.009) -0.424 (0.003)
Social  
functioning
-0.254 (0.011) -0.222 (0.107) -0.217 (0.148)
role-emotional -0.231 (0.021) -0.332 (0.014) 0.077 (0.611)
Mental health -0.374 (,0.001) -0.375 (0.005) -0.352 (0.017)
Note: rs, Spearman’s correlation coefficient.
Abbreviation: SF-36, Medical Outcomes Study 36-item Short-Form health 
Survey.
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015:8submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
540
Sepúlveda et al
are also partially in accordance with the results of two longi-
tudinal studies,30,31 which found that the presence of CVD was 
related to worse physical functioning, general health, vitality, 
mental component,30 and physical component.30,31 Our results 
and those obtained in those studies suggest that CVD causes 
physical and emotional constraints in patients with diabetes. 
With regard to physical impairments, it appears that HRQoL 
and life expectancy of these patients are more reduced, given 
that CVD is the major cause of death in both diabetic males 
and females.32 Thereby, it is not surprising that these patients 
become physically more limited, and, consequently, end up 
becoming psychologically more vulnerable.
Regarding PAD and its relationship with HRQoL,  Sakamaki 
et al13 and Wasem et al17 found no relation between the two 
variables, and surprisingly, Venkataraman et al22 reported that 
patients with PAD had better HRQoL in terms of physical 
functioning, role-physical, and physical component than those 
without PAD. Conversely, we found that PAD was related to 
worse HRQoL in terms of physical functioning, role-physical, 
and general health. Our results are partially in agreement with 
the findings of Silva et al5 and Neves et al,10 because it was 
found that its presence was related to worse HRQoL in terms 
of physical functioning, bodily pain, vitality,5,10 role-physical, 
general health, social functioning, role-emotional, and mental 
health.10 However, it is worth noting that these studies5,10 have 
methodological limitations that might have jeopardized the 
results, namely, the  inclusion of type 1 and type 2 diabetes, and 
the non-adjustment of the HRQoL scores for age. As with dia-
betic retinopathy and nephropathy, PAD had a greater relation-
ship with the  physical component than with the mental one.
Although Wexler et al20 and Hill-Briggs et al25 have found 
no relationship between the presence of HTN and HRQoL, 
in this study HTN was related to worse HRQoL in terms of 
general health and vitality. These findings are partially in 
agreement with the results of prior studies5,10,23,24 - the pres-
ence of HTN was related to lower HRQoL in terms of physical 
functioning, role-physical, bodily pain,5,10 general health,5,10,23 
vitality, social functioning, mental health,10,24 role-emotional,10 
and mental component.24 These differences between the two 
groups may possibly be explained by its frequent association 
with cardiac, cerebrovascular, renal, and ocular complications. 
Isolated HTN (except hypertensive crisis) is usually asymp-
tomatic, and it is through predisposition to associated diseases 
that eventually may help to explain the worse HRQoL of the 
hypertensive patients. On the other hand, various items of the 
SF-36 are somewhat similar to some symptoms of hypoten-
sion and hypoglycemia and, thus, may have contributed to this 
worse HRQoL in the hypertensive patients.
With regard to the relationship between the number of 
diabetes-related chronic complications and HRQoL, while 
Caldwell et al27 reported no relationship between the two 
variables, we found that an increased number of complica-
tions was associated with worse HRQoL in all dimensions 
of SF-36 with the exception of bodily pain dimension. 
These findings are partially in agreement with the results 
of two cross-sectional studies.16,26 In the first study, it was 
found that a higher number of chronic complications was 
related to worse HRQoL in terms of physical and mental 
component, whereas in the latter investigation, an increased 
number of long-term complications was related to worse 
HRQoL in terms of physical functioning, role-physical, 
role-emotional, social functioning, and mental health. On 
the other hand, our results are partially consistent with the 
findings of a longitudinal study33 that have found that an 
increased number of complications predicted lower HRQoL 
in terms of physical and mental components. In the present 
study, the existence of higher number of diabetes-related 
complications suggests a set of physical, emotional, and 
social constraints, which result from the emergence of new 
symptoms, the intensification of the treatment regimen, and 
a feeling of frustration, anger, and failure after the worsen-
ing of diabetes. We also found relevant differences between 
sexes. Different HRQoL dimensions were more strongly 
associated with the number of chronic complications in 
male and female patients.
Some differences in the results between this study and others 
may be explained by the different generic tools used to assess 
HRQoL that do not measure exactly the same dimensions.
Several limitations of this study should be considered when 
interpreting its results. The results would be more robust with 
a larger sample. This would also allow multivariate analysis, 
thus decreasing the confounder effect of the remaining vari-
ables. Multiple testing also must be considered, as it increases 
the occurrence of statistically significant results; however, the 
comparison of our results with prior studies enhances their 
adequate interpretation despite this limitation. Furthermore, 
most of the patients interviewed were of low sociocultural 
status, which may have limited their understanding of the 
questions in the instrument used to assess HRQoL. Gener-
alization of our findings may be limited because our sample 
was collected in a central public hospital and might not be 
representative of the population with type 2 diabetes in other 
care centers or in primary care. Further studies are warranted 
to adjust the dimensions of HRQoL to other variables (eg, sex, 
body mass index, type of diabetes and treatment regimens, 
and duration of the disease) to explore the relationships 
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between HRQoL and the presence of diabetes-related chronic 
 complications and HTN, which we think may explain some of 
these relationships. Further investigations on stratifying the 
severity of diabetes-related chronic complications are required 
because they may bring important complementary informa-
tion. More studies are needed to explore sex differences with 
regard to the association between the number of long-term 
complications and HRQoL and considering different groups 
of complications. Lastly, the use of qualitative methodology 
could be useful to obtain information complementary to that 
achieved by quantitative studies, allowing more accurate 
interpretation of some results.
The current study has various strengths. First, we 
included a more homogeneous sample (ie, only type 2 dia-
betic patients) in comparison to the two previous researches 
carried out in Portugal5,10 which have included both type 1 
and type 2 diabetic patients when assessing the relationship 
between diabetes-related chronic complications, HTN and 
HRQoL without making stratified analyses according to type 
of diabetes. Second, the age-adjustment of the SF-36 values 
to evaluate the relationship between chronic complications, 
HTN and HRQoL, given the age-discrepancies within the 
sample, which was not made in the two mentioned Portuguese 
 investigations. Third, we evaluated the association between 
HRQoL and number of chronic complications by sex, which 
was not made previously,16,26,27 and we think may provide 
important supplemental information.
Conclusion
In summary, our findings suggest that the presence and 
increased number of diabetes-related chronic complications, 
as well as the presence of HTN were related to worse age-
adjusted HRQoL. It is worth noting that among diabetes-
related long-term complications, peripheral neuropathy and 
CVD were more strongly related to patients’ age-adjusted 
HRQoL. In males, there was a strong association between 
the number of chronic complications and HRQoL than in 
their counterparts.
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